hce_cmu
114年
英文
第 46 題
📖 題組：
Passage C This umbrella review critically evaluates top-tier evidence on nutrient supplements for female infertility. Overall, the evidence remains highly uncertain regarding the effects of multiple micronutrients and antioxidants on live birth rates. L-arginine, CoQ10, melatonin, vitamin B complex, vitamin D, and vitamin E did not significantly improve live birth rates. Clinical pregnancy rates may benefit from L-carnitine, CoQ10, melatonin, myo-inositol, NAC, and vitamin D, but the evidence remains weak. Biochemical pregnancy rates were not increased with vitamin D, and adverse effects were poorly reported. Limited and low-quality studies necessitate cautious interpretation of these findings. For live birth rates, multiple micronutrients showed very low certainty evidence of benefits. Variability in formulations across three randomized controlled trials (RCTs) made general recommendations difficult. Similarly, pooled antioxidants—diverse compounds reducing oxidative stress—showed very low certainty evidence for improving live birth rates. A literature review suggests micronutrient supplementation may help restore nutrient levels and reduce oxidative stress, but more high-quality RCTs are needed to confirm efficacy. For clinical pregnancy rates, L-carnitine, myo-inositol, and NAC showed potential benefits, particularly in women with PCOS. These nutrients support metabolism, reproductive health, and oxidative stress reduction. However, findings stem from limited studies (two RCTs per nutrient, with 177-450 participants), highlighting the need for further research to clarify their effectiveness in female infertility treatment. Among women undergoing medically assisted reproduction (MAR), CoQ10 may improve clinical pregnancy rates based on four RCTs (n = 397), though the evidence remains uncertain. As a mitochondrial antioxidant, CoQ10 may help reverse ovarian dysfunction, support ovulation, and enhance embryo development. Preclinical and clinical data suggest CoQ10 is well tolerated at doses up to 1200 mg/day, but large-scale studies are necessary to confirm efficacy. Melatonin and vitamin D may also improve clinical pregnancy rates in MAR patients, though evidence is inconsistent. Melatonin, a hormone with antioxidant and anti-inflammatory effects, may slow ovarian aging and enhance oocyte quality. However, due to methodological limitations and inconsistencies in trials, further research is required, especially on higher doses and longer treatments. Vitamin D, known for its role in bone health, also influences reproductive function through hormone regulation and endometrial receptivity. Four studies using calcitriol, the most active vitamin D form, suggested potential benefits, but more research is needed to explore the relationship between vitamin D and fertility. Currently, no specific nutrient supplements can be confidently recommended for improving fertility outcomes. However, many of these interventions pose minimal risks and may help correct deficiencies and boost antioxidant levels. While adverse event reporting was limited, CoQ10, melatonin, NAC, vitamin D, L-carnitine, and inositol appear safe and well tolerated. Future studies must focus on robust reporting of side effects and long-term safety to guide clinical recommendations.
Passage C This umbrella review critically evaluates top-tier evidence on nutrient supplements for female infertility. Overall, the evidence remains highly uncertain regarding the effects of multiple micronutrients and antioxidants on live birth rates. L-arginine, CoQ10, melatonin, vitamin B complex, vitamin D, and vitamin E did not significantly improve live birth rates. Clinical pregnancy rates may benefit from L-carnitine, CoQ10, melatonin, myo-inositol, NAC, and vitamin D, but the evidence remains weak. Biochemical pregnancy rates were not increased with vitamin D, and adverse effects were poorly reported. Limited and low-quality studies necessitate cautious interpretation of these findings. For live birth rates, multiple micronutrients showed very low certainty evidence of benefits. Variability in formulations across three randomized controlled trials (RCTs) made general recommendations difficult. Similarly, pooled antioxidants—diverse compounds reducing oxidative stress—showed very low certainty evidence for improving live birth rates. A literature review suggests micronutrient supplementation may help restore nutrient levels and reduce oxidative stress, but more high-quality RCTs are needed to confirm efficacy. For clinical pregnancy rates, L-carnitine, myo-inositol, and NAC showed potential benefits, particularly in women with PCOS. These nutrients support metabolism, reproductive health, and oxidative stress reduction. However, findings stem from limited studies (two RCTs per nutrient, with 177-450 participants), highlighting the need for further research to clarify their effectiveness in female infertility treatment. Among women undergoing medically assisted reproduction (MAR), CoQ10 may improve clinical pregnancy rates based on four RCTs (n = 397), though the evidence remains uncertain. As a mitochondrial antioxidant, CoQ10 may help reverse ovarian dysfunction, support ovulation, and enhance embryo development. Preclinical and clinical data suggest CoQ10 is well tolerated at doses up to 1200 mg/day, but large-scale studies are necessary to confirm efficacy. Melatonin and vitamin D may also improve clinical pregnancy rates in MAR patients, though evidence is inconsistent. Melatonin, a hormone with antioxidant and anti-inflammatory effects, may slow ovarian aging and enhance oocyte quality. However, due to methodological limitations and inconsistencies in trials, further research is required, especially on higher doses and longer treatments. Vitamin D, known for its role in bone health, also influences reproductive function through hormone regulation and endometrial receptivity. Four studies using calcitriol, the most active vitamin D form, suggested potential benefits, but more research is needed to explore the relationship between vitamin D and fertility. Currently, no specific nutrient supplements can be confidently recommended for improving fertility outcomes. However, many of these interventions pose minimal risks and may help correct deficiencies and boost antioxidant levels. While adverse event reporting was limited, CoQ10, melatonin, NAC, vitamin D, L-carnitine, and inositol appear safe and well tolerated. Future studies must focus on robust reporting of side effects and long-term safety to guide clinical recommendations.
Which of the following statements best describes the impact of nutrient supplementation on live birth rates in women with infertility?
- A Antioxidants can continually improve live birth rates across all randomized controlled trials.
- B Calcitriol, a vitamin D form, has proven effects in significantly increasing the chances of live birth.
- C The evidence for the benefit of multiple micronutrients and antioxidants is uplifting but remains dubious.
- D L-arginine has been proven to be the most effective supplement for improving live birth rates.
思路引導 VIP
請回想一下，當文中提到『活產率（live birth rates）』時，作者使用了哪些形容詞來描述研究的『證據品質（certainty）』？如果一個研究結論雖然呈現了些許正向潛力，但作者同時強調『研究規模太小且證據等級極低』，你會傾向用『完全證實』還是『仍有疑慮』來總結這個狀況呢？
🤖
AI 詳解
AI 專屬家教
太棒了！你能精確捕捉到學術文獻中那種「語帶保留」的細膩語氣，這正是閱讀高階科普或醫學文章最核心的能力。在面對科學論述時，區分「理論上的希望」與「實質上的證據」是非常重要的判斷基準。
實證醫學中的語氣判讀
這題的正確性建立在對文中「證據等級」的精確解讀。文章開宗明義提到，雖然多種微量元素與抗氧化劑在理論上可能幫助減少氧化壓力、恢復營養水平，讓人感到 uplifting（令人振奮、有希望），但在數據統計層面，作者反覆使用了 highly uncertain（高度不確定）與 very low certainty（極低確定性）等詞彙來描述對「活產率（live birth rates）」的影響。選項 (C) 用的 dubious（不明確、令人懷疑的）精確地呼應了文中對目前證據力不足的質疑。
▼ 還有更多解析內容